Asset Strategy Leader, R&D Aesthetics

Role: Asset Strategy Leader responsible for end-to-end lifecycle management of one or multiple assets, serving as the primary cross-functional and enterprise leader. Objectives include creating and executing integrated global asset strategies that encompass development, registration, manufacturing, and commercialization, with a focus on maximizing asset value aligned with corporate priorities. Responsibilities involve chairing the Asset Strategy Team, developing comprehensive strategies, maintaining strong cross-functional relationships, overseeing deliverables like the Product Development Plan, and guiding key decision points. The role requires strategic oversight, collaborative leadership, and external stakeholder engagement. Qualifications: Bachelor’s degree required; advanced degrees (PhD, MBA) preferred. 5-10+ years in pharma/biotech, with deep expertise in drug development, commercialization, and experience across multiple phases and therapeutic areas, notably in aesthetics devices. Proven leadership in matrixed environments, strong strategic thinking, and influencing senior management are essential. High-value biopharma specifics include lifecycle management of assets in immunology, oncology, neuroscience, or aesthetics, with experience spanning R&D, regulatory, commercial, and manufacturing domains. The position is onsite in Irvine, CA, with no explicit travel requirements stated.